{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:18:03Z","timestamp":1791436683886,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jneuroim.2011.12.003","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T16:46:38Z","timestamp":1326213998000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The effect of TNF-alpha, Fc\u03b3R and CD1 polymorphisms on Guillain\u2013Barr\u00e9 syndrome risk: Evidences from a Meta-Analysis"],"prefix":"10.1016","volume":"243","author":[{"given":"Li-ya","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2011.12.003_bb0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.05.018","article-title":"Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes","volume":"177","author":"Caporale","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2007.03.001","article-title":"Polymorphisms of CD1 genes in chronic dysimmune neuropathies","volume":"186","author":"De Angelis","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0020","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.1115301","article-title":"Assistance of microbial glycolipid antigen processing by CD1e","volume":"310","author":"de la Salle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0167-5699(97)01007-4","article-title":"Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies","volume":"18","author":"Deo","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-051X.2009.01530.x","article-title":"Fcgamma receptor polymorphisms and their association with periodontal disease: a meta-analysis","volume":"37","author":"Dimou","year":"2010","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410340208","article-title":"The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders","volume":"34","author":"Enders","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2004.01.003","article-title":"Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barre patients","volume":"150","author":"Geleijns","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.12.001","article-title":"Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome","volume":"161","author":"Geleijns","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0060","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.4049\/jimmunol.177.6.4211","article-title":"Mannose-binding lectin contributes to the severity of Guillain-Barre syndrome","volume":"177","author":"Geleijns","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2007.07.008","article-title":"Genetic polymorphisms of macrophage-mediators in Guillain-Barre syndrome","volume":"190","author":"Geleijns","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s002770050396","article-title":"The IgG Fc receptor family","volume":"76","author":"Gessner","year":"1998","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0075","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q","article-title":"TNF-alpha gene polymorphism: clinical and biological implications","volume":"50","author":"Hajeer","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"Pt 3","key":"10.1016\/j.jneuroim.2011.12.003_bb0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0090","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3109\/08820139.2010.503768","article-title":"Association of CD1A +622 T\/C, +737 G\/C and CD1E +6129 A\/G genes polymorphisms with multiple sclerosis","volume":"39","author":"Jamshidian","year":"2010","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0095","article-title":"Tumor necrosis factor alpha 308 G\/A polymorphism and Guillain-Barre syndrome risk","author":"Jiao","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0100","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000244468.22377.6b","article-title":"Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies","volume":"67","author":"Kimoto","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jneuroim.2008.08.013","article-title":"Susceptibility to Guillain-Barre syndrome is not associated with CD1A and CD1E gene polymorphisms","volume":"205","author":"Kuijf","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410440517","article-title":"Genetic contribution of the tumor necrosis factor region in Guillain-Barre syndrome","volume":"44","author":"Ma","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0115","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/aje\/kwh069","article-title":"Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review","volume":"159","author":"Ntais","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2009.10.018","article-title":"Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barre syndrome in Northern Indian population","volume":"218","author":"Nyati","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/ard.2010.136283","article-title":"Fcgamma receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis","volume":"70","author":"Okuyama","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10048-003-0144-1","article-title":"Immunoglobulin KM genes in Guillain-Barre syndrome","volume":"4","author":"Pandey","year":"2003","journal-title":"Neurogenetics"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.17.1.297","article-title":"The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids","volume":"17","author":"Porcelli","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.humimm.2010.06.013","article-title":"Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barre syndrome","volume":"71","author":"Prasad","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0150","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/jnnp.74.7.971","article-title":"Apolipoprotein E genotypes and clinical outcome in Guillain-Barre syndrome","volume":"74","author":"Pritchard","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 4","key":"10.1016\/j.jneuroim.2011.12.003_bb0155","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/brain\/118.4.869","article-title":"Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor","volume":"118","author":"Redford","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0160","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barre syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0404.2009.01229.x","article-title":"Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barre syndrome","volume":"122","author":"Sinha","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0170","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/sim.2010","article-title":"A method for meta-analysis of molecular association studies","volume":"24","author":"Thakkinstian","year":"2005","journal-title":"Stat. Med."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0175","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1212\/WNL.54.8.1661","article-title":"IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome","volume":"54","author":"van der Pol","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0180","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/hmg\/11.11.1281","article-title":"Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(\u2212kappa)B transcription factors","volume":"11","author":"van Heel","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2005.01.016","article-title":"Severity of Guillain-Barre syndrome is associated with Fc gamma Receptor III polymorphisms","volume":"162","author":"van Sorge","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.55.5.705","article-title":"IgG Fc-receptor polymorphisms in Guillain-Barre syndrome","volume":"55","author":"Vedeler","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000102162","article-title":"Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome","volume":"58","author":"Zhang","year":"2007","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2011.12.003_bb0200","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/aje\/kwn368","article-title":"Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis","volume":"169","author":"Zintzaras","year":"2009","journal-title":"Am. J. Epidemiol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811003419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811003419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:24Z","timestamp":1759047504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572811003419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0165572811003419"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.12.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of TNF-alpha, Fc\u03b3R and CD1 polymorphisms on Guillain\u2013Barr\u00e9 syndrome risk: Evidences from a Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}